PubRank

B Rosbrook

Author PubWeight™ 40.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Has the California tobacco control program reduced smoking? JAMA 1998 7.38
2 Does tobacco advertising target young people to start smoking? Evidence from California. JAMA 1991 4.63
3 Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med 2000 3.92
4 Telephone counseling for smoking cessation: effects of single-session and multiple-session interventions. J Consult Clin Psychol 1996 3.72
5 Lower levels of cigarette consumption found in smoke-free workplaces in California. Arch Intern Med 1993 3.09
6 Addiction versus stages of change models in predicting smoking cessation. Addiction 1996 2.29
7 Predictors of immediate and 6-month outcomes in hospitalized elderly patients. The importance of functional status. J Am Geriatr Soc 1988 1.66
8 Are adolescents receptive to current sales promotion practices of the tobacco industry? Prev Med 1997 1.65
9 Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial. Br J Cancer 2013 1.65
10 Reducing tobacco consumption in California: Proposition 99 seems to work. JAMA 1991 1.55
11 Impact of the American Stop Smoking Intervention Study on cigarette consumption. Tob Control 1997 1.50
12 Telephone counseling as adjuvant treatment for nicotine replacement therapy in a "real-world" setting. Prev Med 2000 1.45
13 CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone. Br J Cancer 2009 0.98
14 Is stage-of-change a useful measure of the likelihood of smoking cessation? Ann Behav Med 1996 0.93
15 Phase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumours. Br J Cancer 2012 0.86
16 Projecting international lung cancer mortality rates: first approximations with tobacco-consumption data. J Natl Cancer Inst Monogr 1992 0.85
17 Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours. Br J Cancer 2012 0.82
18 Improved survival for frail elderly inpatients on a geriatric evaluation unit (GEU): who benefits? J Clin Epidemiol 1988 0.81
19 Public objections to environmental tobacco smoke. Prev Med 1992 0.78